GATA3 (GATA binding protein 3)

Given the rarity of the tumor, it is crucial to distinguish it from morphological mimics to inform appropriate patient management. Treatment approaches are typically based on protocols for primary breast cancer, given the histological and biological similarities between these tumors and breast tissue.

Importantly, pharmacological targeting of NUDT21 with ouabain octahydrate induces robust apoptosis in T-ALL cells by promoting NUDT21 protein degradation and concomitant suppression of UBE2D3 and MYC. Collectively, our findings establish NUDT21 as a multimodal oncogenic regulator and a promising therapeutic target in T-ALL.

The other familial type of MEN type2 and NF1 are discussed by some characteristic features in histology. Finally, rare types such as ACTH-producing PPGL, and dopamine-producing PPGL are discussed.

SLBZP alleviated NTM-induced lung damage and enhanced NK cell immune response, which might be linked to CD4+ T cell immunity.

This case highlights the importance of recognizing paraganglioma as a potential diagnostic mimic in solitary somatostatin receptor-avid mesenteric nodules to prevent unnecessary investigations and guide appropriate surgical management. Primary mesenteric paragangliomas should be considered in the differential diagnosis of solitary, hypervascularized mesenteric masses.A solitary SSTR-avid mesenteric nodule in an asymptomatic, biochemically silent patient does not necessarily imply nodal metastasis from an occult small intestinal neuroendocrine tumor.Considering alternative diagnoses may avoid unnecessary endoscopic, radiological, and surgical investigations for an intestinal primary lesion.Definitive diagnosis and risk stratification rely on histopathology and immunohistochemistry, including epithelial markers, GATA3, and SDHB.Awareness of mesenteric paraganglioma as a diagnostic mimic can prevent overtreatment and guide appropriate surgical management.

These findings suggest that the two components are part of the same neoplastic process and, given the presence of urothelial carcinoma in situ, possibly represent the first reported example of urothelial carcinoma with divergent prostatic differentiation. Awareness of divergent differentiation in urothelial carcinomas has important diagnostic, prognostic and therapeutic implications and can be resolved with the use of ancillary molecular studies.

Accurate distinction of poorly differentiated prostate carcinoma from urothelial carcinoma requires correlation with prior diagnoses and a focused immunohistochemical panel, as misclassification carries significant therapeutic implications. Pathologists should maintain awareness of this uncommon mimic.

Early endoscopic assessment and immunohistochemical confirmation were key to diagnosis. Clinicians should maintain a high index of suspicion for atypical metastatic patterns in patients with advanced breast carcinoma.

The patient had been receiving fulvestrant for known pulmonary metastasis diagnosed 14 years prior...Treatment with S-1 resulted in radiological improvement at four months. This case adds to the limited literature documenting OP-mimicking pulmonary metastasis from breast cancer and highlights the importance of maintaining a high index of suspicion and pursuing tissue diagnosis in patients with a history of breast cancer who present with new pulmonary infiltrates.

The patient received postoperative radiotherapy. At 6 months of follow-up, metastasis to the right inguinal lymph nodes was identified.

CENETS are rare and often misdiagnosed. Serpentine dilated vessel identification at the tumor's cephalad part during surgery may be indicative, and gross total resection be curative.